Targeting the Melanoma Glycome to Improve Immune Checkpoint Inhibitor Therapy Grant

Targeting the Melanoma Glycome to Improve Immune Checkpoint Inhibitor Therapy .

date/time interval

  • May 1, 2020 - April 30, 2021

awarded by

administered by

sponsor award ID

  • 2400160

local award ID

  • AWD000000011477

contributor